The compound library is the reference section of Amino Axiom, a free research information platform. It lists 58 research compounds, and each entry brings together sourced notes on mechanism, structure and regulatory status. Its compound library is meant for background reading before bench work begins. This article compares that structured approach with the manual alternative, using three neuropeptide compounds as worked examples. It describes information handling only; nothing here concerns use of any material outside laboratory research.
How do researchers usually build neuropeptide background by hand?
Most researchers start with a folder of saved papers, a notes document, and a spreadsheet. For each compound the same questions come up: what is its structure, how is it classified, what is its mechanism as described in the literature, and how is it regulated. Each answer is assembled from a different source, a supplier sheet for the formula, a review article for the mechanism, a regulatory notice for the status.
The manual route has real strengths. It is free, it can be bent around any question, and it forces direct contact with primary sources. Researchers who build their own files tend to remember them well. The weaknesses are mostly about repetition and drift:
The same lookups are repeated for every new compound, and the notes layout changes from one compound to the next.
Facts are typed from memory or copied from a single supplier sheet, so a transcription error propagates quietly.
Regulatory status changes over time, and a note written months ago can be out of date without any visible sign.
Comparing two compounds means opening two differently organized files.
What does a structured library entry add?
A library entry puts each of those questions in a predictable location. Structure, mechanism and regulatory status are separate, labeled parts, each carrying its sources. Because every one of the 58 entries uses the same layout, reading a second compound takes less effort than reading the first, and a fact that is missing is visibly missing rather than silently absent from a file.
The library is also connected to the rest of the platform. Compound names resolve to the same record wherever they appear, which removes the naming drift common in spreadsheets, where "Semax", "semax 5mg" and "SEMAX-A" all stand for one thing. The library does not describe or imply any use of the material. It is a reference surface, and this article treats it as exactly that.
How does the comparison look at a glance?
The table below summarizes where each approach tends to be stronger for neuropeptide background work.
Question
Doing it by hand
Amino Axiom compound library
Layout across compounds
Varies with each file
Same sections for all 58 entries
Where facts come from
Whatever was saved
Sourced entries per section
Naming consistency
Depends on the researcher
One record per compound
Staleness of status notes
Invisible until checked
Single place to re-check
Direct contact with papers
Built in
Still the researcher's step
Cost and control
Free, fully local
Free, hosted
Neither column wins everywhere. The library helps with consistency and comparison; the manual file wins on control and on forcing a close reading of primary sources.
How does the comparison play out for Semax?
Semax is a good case because it is a single, defined molecule. In the Neurolevel catalog its CAS number is 80714-61-0, its molecular formula is C37H51N9O10S, and its molecular weight is 813.93 g/mol. By hand, those three facts are typed into a notes column once and retyped whenever a second file needs them. A single wrong digit in a formula with subscripts is easy to introduce and hard to notice.
In a structured entry, the identity facts live in one labeled structure section, so a researcher compares them against a supplier certificate rather than against a personal note. The practical gain is not speed so much as a shared reference point. Checking the catalog values against a certificate of analysis is still a manual scientific step in either system.
How does the comparison play out for Selank?
Selank shows the naming problem. It is a synthetic analog of a naturally occurring tetrapeptide and is regularly discussed alongside Semax, since both were developed in the same research tradition. A hand-built file that covers both can easily mix their notes, especially when a row is copied and edited.
The Neurolevel catalog lists Selank at CAS 129954-34-3, formula C33H57N11O9, molecular weight 751.86 g/mol. Those numbers differ from Semax in every field, and a library that keeps the two as separate records means copied text cannot carry the wrong molecular data across. Reading the two entries side by side, a researcher can see at once that the sequences, masses and published mechanistic framing are distinct, which is harder to see in two unrelated notes files.
How does the comparison play out for Cerebrolysin?
Cerebrolysin is the most instructive case because it does not fit a template built for single molecules. It is a complex mixture of low-molecular-weight peptides and free amino acids from enzymatic hydrolysis of porcine brain tissue, catalogued under CAS 12656-61-0. The Neurolevel catalog gives its molecular weight as approximately 10,000 g/mol for the low-molecular-weight mixture and carries no single molecular formula, because a mixture has none.
A hand-built file often forces a formula into a column that expects one, and a guessed value then sits in the notes looking authoritative. A structured entry can state plainly that the structure section describes a mixture. Published characterization work describes the preparation as variable in composition, which is why the existing Neurolevel article on the Cerebrolysin neuropeptide mixture treats lot traceability as part of study design. Background reading in a library does not resolve that variability; it makes the limitation visible before a study is planned.
Where does the manual approach still win?
A fair comparison includes the cases where doing it by hand is the better choice.
Narrow projects. A bench working on one compound gains little from a 58-compound library.
Primary-source depth. Writing a methods section requires reading the original papers, which no summary section replaces.
Institutional requirements. Some groups must keep records in a validated internal system.
Control. A local file does not depend on a hosted platform remaining available.
How should a researcher use the library responsibly?
The library is background, not verification. It describes what a compound is in general; it does not describe the lot on a specific shelf. Identity, purity and handling statements come from supplier documents and the researcher's own analysis. A sound habit under either approach is to record where each fact came from, and to treat any mismatch between a note and a source document as a reason to stop and check.
Neurolevel's catalog pages for Semax, Selank and Cerebrolysin list the specifications cited above. General information about the platform itself is on the Amino Axiom site.
This compound is a research chemical intended for laboratory and scientific research purposes only. It is not a drug, supplement, or food, and is not intended to diagnose, treat, cure, or prevent any disease. Neurolevel does not sell products intended for human use. Researchers are responsible for compliance with all applicable local, state, and federal regulations.
Reference
Common questions
The compound library is a free section of the Amino Axiom research platform that lists 58 research compounds. Each entry organizes sourced information on mechanism, structure and regulatory status in one place. It is an information resource for background reading, and it makes no claim about use of any material outside laboratory research.
A library entry follows the same layout for every compound, so mechanism, structure and regulatory status sit in predictable places. A hand-built file reflects whatever the researcher gathered and in whatever order. The structured layout reduces repeated lookups, but it does not replace reading the primary literature directly.
Cerebrolysin is a complex mixture of low-molecular-weight peptides and free amino acids from enzymatic hydrolysis of porcine brain tissue, not one defined molecule. A single formula therefore does not describe it. The Neurolevel catalog lists it as a peptide mixture of roughly 10,000 g/mol, for research use only.
No. A library describes what a compound is in general, while a certificate of analysis describes a specific lot. Identity, purity and handling statements for material actually on a bench come from supplier documents and the researcher's own analysis. The library supplies background context only, for research purposes only.
